1. Home
  2. NVNI vs NEPH Comparison

NVNI vs NEPH Comparison

Compare NVNI & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNI
  • NEPH
  • Stock Information
  • Founded
  • NVNI 2019
  • NEPH 1997
  • Country
  • NVNI Brazil
  • NEPH United States
  • Employees
  • NVNI N/A
  • NEPH N/A
  • Industry
  • NVNI
  • NEPH Medical/Dental Instruments
  • Sector
  • NVNI
  • NEPH Health Care
  • Exchange
  • NVNI Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • NVNI 57.2M
  • NEPH 57.2M
  • IPO Year
  • NVNI N/A
  • NEPH 2004
  • Fundamental
  • Price
  • NVNI $4.13
  • NEPH $4.89
  • Analyst Decision
  • NVNI
  • NEPH Strong Buy
  • Analyst Count
  • NVNI 0
  • NEPH 2
  • Target Price
  • NVNI N/A
  • NEPH $5.50
  • AVG Volume (30 Days)
  • NVNI 1.3M
  • NEPH 72.5K
  • Earning Date
  • NVNI 09-30-2025
  • NEPH 11-06-2025
  • Dividend Yield
  • NVNI N/A
  • NEPH N/A
  • EPS Growth
  • NVNI N/A
  • NEPH N/A
  • EPS
  • NVNI N/A
  • NEPH 0.12
  • Revenue
  • NVNI $31,250,627.00
  • NEPH $16,684,000.00
  • Revenue This Year
  • NVNI $12.05
  • NEPH $24.38
  • Revenue Next Year
  • NVNI $15.02
  • NEPH $10.16
  • P/E Ratio
  • NVNI N/A
  • NEPH $41.03
  • Revenue Growth
  • NVNI 1491.58
  • NEPH 21.16
  • 52 Week Low
  • NVNI $1.44
  • NEPH $1.36
  • 52 Week High
  • NVNI $121.90
  • NEPH $5.98
  • Technical
  • Relative Strength Index (RSI)
  • NVNI 71.42
  • NEPH 51.58
  • Support Level
  • NVNI $2.96
  • NEPH $5.12
  • Resistance Level
  • NVNI $4.94
  • NEPH $5.74
  • Average True Range (ATR)
  • NVNI 0.51
  • NEPH 0.50
  • MACD
  • NVNI 0.21
  • NEPH -0.02
  • Stochastic Oscillator
  • NVNI 83.44
  • NEPH 25.85

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: